SCHEMBL3406178

SCHEMBL3406178

Nc1cnccc1N(C(=O)O)C1CNCCC1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
MEN1 O00255 1/20 0.38
KDM6B O15054 1/20 0.38
KDM4A O75164 1/20 0.38
MAPT P10636 1/20 0.38
THRB P10828 1/20 0.38
KMT2A Q03164 1/20 0.38
KDM4D Q6B0I6 1/20 0.38
KDM4C Q9H3R0 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
RPS6KA3 P51812 1/20 0.35
MKNK1 Q9BUB5 1/20 0.33
MKNK2 Q9HBH9 1/20 0.33
GLA P06280 1/20 0.32
GAA P10253 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
SLC6A3 Q01959 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3406173 1.00 KDM4E (0.38) KDM4EALDH1A1MEN1KDM6BKDM4A
SCHEMBL3415524 1.00 KDM4E (0.38) KDM4EALDH1A1MEN1KDM6BKDM4A
SCHEMBL1710253 0.82 MEN1 (0.35) ALDH1A1MEN1MAPTKMT2ARPS6KA3
SCHEMBL3233538 0.82 MEN1 (0.35) ALDH1A1MEN1MAPTKMT2ARPS6KA3
SCHEMBL4436107 0.82 MEN1 (0.35) ALDH1A1MEN1MAPTKMT2ARPS6KA3
SCHEMBL3412017 0.80 RPLP1 (0.41) KDM4EALDH1A1MEN1KDM6BKDM4A
SCHEMBL4436056 0.79 PIM2 (0.38) PIM1PIM3PIM2
SCHEMBL1710369 0.78 KDM4E (0.32) KDM4EALDH1A1MEN1KDM6BKDM4A
SCHEMBL3228821 0.78 KDM4E (0.32) KDM4EALDH1A1MEN1KDM6BKDM4A
SCHEMBL1710373 0.78 KDM4E (0.32) KDM4EALDH1A1MEN1KDM6BKDM4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2262802-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE Novartis AG (CH) 2010-12-22 EP disclosed
EP-2132177-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE Novartis Ag (CH) 2009-12-16 EP disclosed
WO-2009109576-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE NOVARTIS AG (CH) 2009-09-11 WO disclosed
WO-2008106692-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2008-09-04 WO disclosed